{"entity":{"id":"cancer-biology-and-therapy","kind":"journal","name":"Cancer biology & therapy","aka":["Cancer Biology & Therapy","Cancer Biology and Therapy","Cancer Biol Ther"],"tldr":"Cancer Biology & Therapy is an open access journal on the molecular basis of cancer and its translation into diagnosis and treatment, read by translational cancer researchers.","summary":"Cancer Biology & Therapy began in 2002 with Landes Bioscience, which Crossref still names, and has been published by Taylor & Francis from Philadelphia since 2015. Its aims and scope describe an international journal examining all aspects of the molecular basis of cancer with translational relevance to diagnosis and therapy, covering new technologies, mechanisms of action of novel agents, combination chemotherapy, pharmacogenomics and pharmacokinetics, and chemotherapeutic, biological, immunomodulatory, cell and gene therapies. It publishes original research, reviews, meeting reports, bedside-to-bench reports, letters and journal club articles under single-blind peer review, converted to full open access from volume 23 in 2022 and is now online only. Listed in DOAJ with CC BY and CC BY-NC licences and an article processing charge. Indexed in MEDLINE.","asOf":"2026-09-10","links":[{"label":"Homepage","url":"https://www.tandfonline.com/journals/kcbt"},{"label":"NLM Catalog","url":"https://www.ncbi.nlm.nih.gov/nlmcatalog/101137842"},{"label":"DOAJ record","url":"https://doaj.org/toc/1538-4047"}],"tags":[],"related":["pubmed-europepmc"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pharmacokinetics","preclinical"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Taylor & Francis (formerly Landes Bioscience)","url":"https://www.tandfonline.com/journals/kcbt","issn":"1538-4047","scope":"cancer biology and therapeutics","access":"open-access","founded":2002,"matchNames":["Cancer Biol Ther","Cancer biology & therapy","Cancer Biology & Therapy","Cancer Biology and Therapy"]},"route":"/journals/cancer-biology-and-therapy/","neighbours":{"collection":[{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"term":[{"id":"pharmacokinetics","kind":"term","name":"Pharmacokinetics (PK), half-life and exposure","route":"/terms/pharmacokinetics/"},{"id":"preclinical","kind":"term","name":"Preclinical","route":"/terms/preclinical/"}],"section":[{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}]}}